Roflumilast 42571-0259-17
- Manufacturer
- Micro Labs Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 19, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA208180
Need to source Roflumilast? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Roflumilast | 500 ug/1 |
Drug Class
Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitors [MoA]
Selected Package
42571-0259-17Selected11 BLISTER PACK in 1 CARTON (42571-259-17) / 10 TABLET in 1 BLISTER PACK (42571-259-32)
Other packages for this product(3)
500 TABLET in 1 BOTTLE (42571-259-05)
30 TABLET in 1 BOTTLE (42571-259-30)
90 TABLET in 1 BOTTLE (42571-259-90)